A method of identifying a subject at risk of a disease or disorder associated with amyloid aggregation includes assaying for Aggregatin in a bodily sample obtained from the subject, wherein the subject is at risk of having the disease or disorder if the Aggregatin is present above a threshold level.
METHODS AND COMPOSTIONS OF DETECTING AND TREATING NEURODEGENERATIVE DISORDERS